american academy of dermatology position glutathione skin lightening for SkinMed Dermatology and Laser Center

466, www.ncbi.nlm.nih.gov/pmc/articles/PMC3178961/, 10.4103/0975-7406.84471

141B : 947956

Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis

Emerging therapies, including Rho-kinase inhibitors and adenosine receptor ligands, show promise for improving AH outflow and offering neuroprotection for RGCs (95)

However, certain circumstances may warrant testing including pre-existing liver or kidney conditions where monitoring organ function during therapy provides appropriate oversight, specific health concerns that might benefit from objective biomarker assessment, desire to objectively measure oxidative stress markers or glutathione status before and during therapy, and medical conditions requiring monitoring for safety reasons